New DNA booster vaccine targets omicron variants
NCT ID NCT06436911
Summary
This study tested a new COVID-19 booster vaccine designed to protect against newer virus variants like Omicron. It involved 46 generally healthy adults who had already received their primary COVID-19 vaccinations. Researchers gave participants a single booster shot to check if it was safe and if it boosted their immune response against the virus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centricity Research
Burlington, Ontario, L7M4Y1, Canada
-
Centricity Research
Toronto, Ontario, M4G3E8, Canada
-
Centricity Research
Toronto, Ontario, M9W4L6, Canada
-
Diex Recherche
Sherbrooke, Quebec, J1L0H8, Canada
-
Diex Recherche Quebec
Québec, Quebec, G1V4T3, Canada
-
University of Alberta
Edmonton, Alberta, Canada
Conditions
Explore the condition pages connected to this study.